# Candesartan Versus Propranolol for Migraine Prevention

> **NCT00884663** · PHASE2,PHASE3 · COMPLETED · sponsor: **Norwegian University of Science and Technology** · enrollment: 72 (actual)

## Conditions studied

- Migraine Without Aura
- Migraine With Aura
- Chronic Migraine

## Interventions

- **DRUG:** Candesartan
- **DRUG:** propranolol
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00884663
- **Lead sponsor:** Norwegian University of Science and Technology
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2012-03
- **Final completion:** 2012-03
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2013-12-24

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00884663

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00884663, "Candesartan Versus Propranolol for Migraine Prevention". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00884663. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*